Integrating Research & Development, Regulatory Affairs, and Project Management in Pharmaceutical Product Development: A Cross-Functional Review

This is the authors' abstract. We don't add key points for this paper.

The successful transformation of a pharmaceutical product concept into a commercially available medicine depends on the tightly coordinated efforts of functions such as: Research & Development (R&D), Regulatory Affairs, Technology Transfer, Commercial Team (Production, Quality control, Quality Assurance), and Project Management. This review examines the scientific activities underpinning R&D, including formulation design, analytical method development, and the instrumentation—such as High-Performance Liquid Chromatography, UV-Visible and Fourier Transform Infrared spectrophotometry, dissolution testing, and tablet-evaluation equipment—used to ensure product quality and stability. It then reviews the regulatory framework governing product registration, centered on the Common Technical Document (CTD) structure and its five modules, the Abbreviated New Drug Application (ANDA) pathway in the United States, and country-specific dossier requirements for European and Rest-of-World markets. Finally, the review considers the coordinating role of Project Management, which links R&D, Regulatory Affairs, Procurement, and Manufacturing through structured milestone tracking and reporting systems. The review argues that effective pharmaceutical development depends not on the excellence of any single function but on the disciplined integration of scientific, regulatory, and managerial processes across the entire product life cycle.